— Organigram Holdings Inc. (NASDAQ: OGI) reported a net loss from continuing operations of $9 million for the first quarter of 2020, vs. a profit of $29.5 million last year.
— Loss per share was $0.006, compared to earnings per share of $0.195 per share in the year-ago period
— First-quarter net revenues more than doubled to $25.15 million from $12.44 million last year
— Gross margin, before fair value changes to biological assets and inventories, rose to $9.3 million from $8.8 million a year earlier
— Adjusted EBITDA was $4.9 million during the three-month period, compared to $6.8 million in the first quarter of 2019
— Expects to start shipping Edison + Feather ready-to-go distillate pens before the end of January 2020
— Plans to launch cannabis-infused dissolvable powder product in the second quarter of calendar 2020
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
Comments
Comments are closed.